Analysis reportAll specifications met
Retatrutide 30mg
Peptide Stock ref. PSV-2608-RT30-01
Purity99.81%HPLC
Content per vial30.75 mg102.5% of 30 mg label claim
IdentityConfirmedGLP-1 blind test (semaglutide, tirzepatide, retatrutide)
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (GLP-1 blind test) | Identify semaglutide, tirzepatide or retatrutide | Retatrutide | Pass |
| Retatrutide content | — | 30.75 mg (102.5% of claim) | Reported |
| Purity | — | 99.806% | Reported |
About this report
- Sample received by the lab 3 August 2026; report issued 6 August 2026.
- Results relate to the sample tested. For laboratory research use only.